NVIDIA, King’s College London develop federated learning system for medical imaging

Researchers from NVIDIA and King’s College London have collaborated on a new federated learning system specifically designed for the interpretation of medical images.

Federated learning involves training a deep neural network with data from multiple healthcare providers, giving participants the ability to work together on a shared model without actually sharing patient data. The practice is viewed as a much more secure way to train neural networks.

“Each node trains its own local model and, periodically, submits it to a parameter server,” the team explained in its paper, as quoted in a prepared statement from NVIDIA. “The server accumulates and aggregates the individual contributions to yield a global model, which is then shared with all nodes.”

The researchers worked with a dataset that included MRI scans more than 250 patients with brain tumors. They found that their approach resulted in “a comparable segmentation performance” that kept the institutions’ data more secure.

“Federated learning has the potential of effectively aggregating knowledge across institutions learned locally from private data, thus further improving the accuracy, robustness, and generalization ability of the deep models,” according to the statement from NVIDIA.

Researchers who worked on this project will be sharing their findings at MICCAI 2019 in Shenzhen, China.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias. 

Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.